APA

Ramsey L. B., Johnson S. G., Caudle K. E., Haidar C. E., Voora D., Wilke R. A., Maxwell W. D., McLeod H. L., Krauss R. M., Roden D. M., Feng Q., Cooper-DeHoff R. M., Gong L., Klein T. E., Wadelius M. & Niemi M. (20141124). The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. : Clinical pharmacology and therapeutics.

Chicago

Ramsey L B, Johnson S G, Caudle K E, Haidar C E, Voora D, Wilke R A, Maxwell W D, McLeod H L, Krauss R M, Roden D M, Feng Q, Cooper-DeHoff R M, Gong L, Klein T E, Wadelius M and Niemi M. 20141124. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. : Clinical pharmacology and therapeutics.

Harvard

Ramsey L. B., Johnson S. G., Caudle K. E., Haidar C. E., Voora D., Wilke R. A., Maxwell W. D., McLeod H. L., Krauss R. M., Roden D. M., Feng Q., Cooper-DeHoff R. M., Gong L., Klein T. E., Wadelius M. and Niemi M. (20141124). The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. : Clinical pharmacology and therapeutics.

MLA

Ramsey L B, Johnson S G, Caudle K E, Haidar C E, Voora D, Wilke R A, Maxwell W D, McLeod H L, Krauss R M, Roden D M, Feng Q, Cooper-DeHoff R M, Gong L, Klein T E, Wadelius M and Niemi M. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. : Clinical pharmacology and therapeutics. 20141124.